| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Ilse Smolders | Q72992945 |
| Dimitri De Bundel | Q56863107 | ||
| P2093 | author name string | Yvette Michotte | |
| Patrick Vanderheyden | |||
| P2860 | cites work | A synaptic model of memory: long-term potentiation in the hippocampus | Q22337276 |
| Purification, characterization, and cloning of a cytosolic aspartyl aminopeptidase | Q24308332 | ||
| GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier | Q24309065 | ||
| Human placental leucine aminopeptidase/oxytocinase. A new member of type II membrane-spanning zinc metallopeptidase family | Q24315214 | ||
| Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path | Q24538964 | ||
| Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy | Q24650174 | ||
| Expression of placental leucine aminopeptidase/oxytocinase in neuronal cells and its action on neuronal peptides | Q28199101 | ||
| The V1a vasopressin receptor is necessary and sufficient for normal social recognition: a gene replacement study | Q28267455 | ||
| 2-Deoxy-D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure | Q28268494 | ||
| Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory | Q28511894 | ||
| Cloning and characterization of a novel insulin-regulated membrane aminopeptidase from Glut4 vesicles | Q28569814 | ||
| Involvement of the somatostatin-2 receptor in the anti-convulsant effect of angiotensin IV against pilocarpine-induced limbic seizures in rats | Q28570454 | ||
| Involvement of D1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe6 angiotensin IV | Q28573288 | ||
| Spatial memory formation and memory-enhancing effect of glucose involves activation of the tuberous sclerosis complex-Mammalian target of rapamycin pathway | Q28575179 | ||
| Distribution and cellular localization of insulin-regulated aminopeptidase in the rat central nervous system | Q28579048 | ||
| The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro | Q28579223 | ||
| Signaling by hepatocyte growth factor in neurons is induced by pharmacological stimulation of synaptic activity | Q28583624 | ||
| Learning induces long-term potentiation in the hippocampus | Q29619482 | ||
| Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task | Q30305450 | ||
| Vasopressin is a physiological substrate for the insulin-regulated aminopeptidase IRAP. | Q30444206 | ||
| Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose | Q30453913 | ||
| Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data | Q30744678 | ||
| Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells | Q30827800 | ||
| Characterization and signaling of the AT(4) receptor in human proximal tubule epithelial (HK-2) cells | Q31961569 | ||
| Distribution of angiotensin IV binding sites (AT4 receptor) in the human forebrain, midbrain and pons as visualised by in vitro receptor autoradiography. | Q32025740 | ||
| Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow | Q32036552 | ||
| Therapeutic targeting of insulin-regulated aminopeptidase: heads and tails? | Q33300628 | ||
| Role of vasopressin in learning and memory in the hippocampus | Q33540677 | ||
| Brain somatostatin: a candidate inhibitory role in seizures and epileptogenesis. | Q33785713 | ||
| Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells | Q33869866 | ||
| A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus | Q33898132 | ||
| Neuromodulation of memory in the hippocampus by vasopressin | Q34060981 | ||
| The human hippocampus and spatial and episodic memory | Q34145961 | ||
| The brain renin-angiotensin system: location and physiological roles. | Q34188368 | ||
| Angiotensin III: a central regulator of vasopressin release and blood pressure. | Q34214360 | ||
| The angiotensin IV/AT4 receptor. | Q34368921 | ||
| AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation. | Q34475220 | ||
| Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice. | Q34520314 | ||
| Fear conditioning occludes LTP-induced presynaptic enhancement of synaptic transmission in the cortical pathway to the lateral amygdala | Q34522595 | ||
| Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory | Q34558801 | ||
| A double leucine within the GLUT4 glucose transporter COOH-terminal domain functions as an endocytosis signal | Q72196778 | ||
| Further evidence for the interactions between angiotensin II and GABAergic transmission in pentylenetetrazol kindling seizures in mice | Q72227279 | ||
| AT4 receptor binding characteristics: D-amino acid- and glycine-substituted peptides | Q72714925 | ||
| The major protein of GLUT4-containing vesicles, gp160, has aminopeptidase activity | Q72863799 | ||
| Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes | Q72888964 | ||
| Central angiotensin IV binding sites: distribution and specificity in guinea pig brain | Q72922615 | ||
| Structure-binding studies of the adrenal AT4 receptor: analysis of position two- and three-modified angiotensin IV analogs | Q73034958 | ||
| Behavioural activity of angiotensin II (3-7)4Phe--analogue of natural fragment 3-7 of angiotensin II | Q73040034 | ||
| Drug-induced changes in cerebral glucose consumption in bifrontal epilepsy | Q73766333 | ||
| Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes | Q73777327 | ||
| Important role for angiotensin III and IV in the brain renin-angiotensin system | Q73881047 | ||
| Location of renin-angiotensin system components in the hypoglossal nucleus of the rat | Q74338116 | ||
| Characterization of AT4 receptor from bovine aortic endothelium with photosensitive analogues of angiotensin IV | Q74378067 | ||
| Differential kinetics of circulating angiotensin IV and II after treatment with angiotensin II type 1 receptor antagonist and their plasma levels in patients with chronic renal failure | Q74590081 | ||
| Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells | Q77355294 | ||
| Structural analysis of angiotensin IV receptor (AT4) from selected bovine tissues | Q77362773 | ||
| Characterization and purification of the bovine adrenal angiotensin IV receptor (AT4) using [125I]benzoylphenylalanine-angiotensin IV as a specific photolabel | Q77387940 | ||
| Adenosine-angiotensin II interactions in pentylenetetrazol seizure threshold in mice | Q77982381 | ||
| Combination of non-hypotensive doses of valsartan and enalapril improves survival of spontaneously hypertensive rats with endothelial dysfunction | Q77985786 | ||
| Ang II and Ang III modulate PTZ seizure threshold in non-stressed and stressed mice: possible involvement of noradrenergic mechanism | Q79256729 | ||
| Nano-LC-MS/MS for the monitoring of angiotensin IV in rat brain microdialysates: limitations and possibilities | Q80771358 | ||
| The brain as an endocrine target for Peptide hormones | Q81065665 | ||
| Glial-specific ablation of angiotensinogen lowers arterial pressure in renin and angiotensinogen transgenic mice | Q81084463 | ||
| Synaptic mechanisms in the kindled epileptic focus: a speculative synthesis | Q39440396 | ||
| The central effects of the renin-angiotensin system | Q39633203 | ||
| Sub-cellular localization of insulin-regulated membrane aminopeptidase, IRAP to vesicles in neurons | Q40132721 | ||
| Involvement of insulin-regulated aminopeptidase and/or aminopeptidase N in the angiotensin IV-induced effect on dopamine release in the striatum of the rat. | Q40196455 | ||
| Conformational induction is the key process for activation of the AT1 receptor | Q40341077 | ||
| Location and secretion of brain angiotensinogen | Q40465215 | ||
| The angiotensin IV system: functional implications | Q40537981 | ||
| Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key! | Q40711842 | ||
| Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. | Q40768845 | ||
| Characterization of the AT(4) receptor in a human neuroblastoma cell line (SK-N-MC). | Q40819711 | ||
| Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands | Q40917544 | ||
| Amygdala role in conditioned associative learning | Q40929772 | ||
| A globin fragment, LVV-hemorphin-7, induces [3H]thymidine incorporation in a neuronal cell line via the AT4 receptor | Q40945054 | ||
| Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions | Q40955661 | ||
| Enhanced angiotensin converting enzyme binding in arteries from spontaneously hypertensive rats | Q41087594 | ||
| Behavioral consequences of intracerebral vasopressin and oxytocin: focus on learning and memory | Q41176049 | ||
| Angiotensin IV receptors and signaling in opossum kidney cells | Q41279017 | ||
| Quantification of renin mRNA in various mouse tissues by a novel solution hybridization assay | Q41284468 | ||
| Expression of the renin gene in extra-renal tissues of the rat. | Q42164047 | ||
| Angiotensin and renin in rat and dog brain | Q42257445 | ||
| Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. | Q42461232 | ||
| Mitogen-activated protein kinase upregulates the dendritic translation machinery in long-term potentiation by controlling the mammalian target of rapamycin pathway | Q42513430 | ||
| Characterization of the insulin-regulated membrane aminopeptidase in 3T3-L1 adipocytes | Q42517117 | ||
| Participation of angiotensin II in learning and memory. I. Interaction of angiotensin II with saralasin | Q48463004 | ||
| Identification of an AII(3-8) [AIV] binding site in guinea pig hippocampus. | Q48467453 | ||
| Membrane Localization of Endopeptidase‐24.11 and Peptidyl Dipeptidase A (Angiotensin Converting Enzyme) in the Pig Brain: A Study Using Subcellular Fractionation and Electron Microscopic Immunocytochemistry | Q48478626 | ||
| Angiotensin II blocks hippocampal long-term potentiation | Q48608093 | ||
| Excitatory action of angiotensins II and IV on hippocampal neuronal activity in urethane anesthetized rats | Q48682751 | ||
| The globin fragment LVV-hemorphin-7 is an endogenous ligand for the AT4 receptor in the brain | Q48701785 | ||
| The long and winding road to memory consolidation | Q48723995 | ||
| Intrahippocampal injections of somatostatin dissociate acquisition from the flexible use of place responses | Q48794686 | ||
| The effect of angiotensin II and its fragments on post-alcohol impairment of learning and memory | Q48822233 | ||
| The effect on drinking of peptide precursors and of shorter chain peptide fragments of angiotensin II injected into the rat's diencephalon | Q48833033 | ||
| Drinking induced by injection of angiotensin into the rain of the rat. | Q48900874 | ||
| Angiotensin II-(3-8)-hexapeptide affects motor activity, performance of passive avoidance and a conditioned avoidance response in rats | Q48934009 | ||
| Distribution of AT4 receptors in the Macaca fascicularis brain | Q49055335 | ||
| Behavioral effects of angiotensin II microinjected into CA1 hippocampal area. | Q51105897 | ||
| Effects of the selective angiotensin II receptor antagonists losartan and PD123177 in animal models of anxiety and memory. | Q51112004 | ||
| Interactions between angiotensin II, diazepam, clonazepam and di-n-propylacetate in pentylenetetrazol kindling seizures in mice. | Q51714736 | ||
| Interactions between angiotensin II, GABA and diazepam in convulsive seizures. | Q51809554 | ||
| Effect of chronic angiotensin converting enzyme inhibition on spatial memory and anxiety-like behaviours in rats. | Q51978955 | ||
| Cognitive effects attributed to angiotensin II may result from its conversion to angiotensin IV. | Q52002341 | ||
| Identification of angiotensin IV binding sites in the mouse brain by a fluorescent binding study. | Q52023364 | ||
| Lateralized learning and memory effects of angiotensin II microinjected into the rat CA1 hippocampal area. | Q52027260 | ||
| Dynorphin A-(1-13) and (2-13) improve beta-amyloid peptide-induced amnesia in mice. | Q52028333 | ||
| Long-term inhibition of renin-angiotensin system sustains memory function in aged Dahl rats. | Q52032035 | ||
| Losartan improves the performance of ethanol-intoxicated rats in an eight-arm radial maze. | Q52041633 | ||
| CGP 42112A abolishes facilitation of recognition caused by angiotensin II and angiotensin II(3-7) in rats. | Q52044669 | ||
| Losartan influences behavioural effects of angiotensin II in rats. | Q52046502 | ||
| Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. | Q52048507 | ||
| Somatostatin alleviates impairment of working memory induced by hippocampal muscarinic M1 receptor blockade in rats. | Q52055540 | ||
| Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and non-cholinomimetic drugs using a novel task in the 12-arm radial maze. | Q52068549 | ||
| Interactions between angiotensin II and baclofen in shuttle-box and passive avoidance performance. | Q52121193 | ||
| Effect of angiotensin II and saralasin on motor activity and the passive avoidance behavior of rats | Q52123912 | ||
| Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog. | Q52185174 | ||
| The contribution of AT1 and AT2 angiotensin receptors to its cognitive effects. | Q52203718 | ||
| Impaired retention by angiotensin II mediated by the AT1 receptor. | Q52211161 | ||
| Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats. | Q52217759 | ||
| Dopaminergic influence on the effects of angiotensin II in behavioural reactions. | Q52270882 | ||
| ACE inhibitors and the kidney. | Q53773106 | ||
| Angiotensin IV Activates the Nuclear Transcription Factor-κB and Related Proinflammatory Genes in Vascular Smooth Muscle Cells | Q61854944 | ||
| Adaptive changes in the effects of angiotensin II on the convulsive-seizure threshold in cases of altered sensitivity of dopamine receptors | Q68455462 | ||
| Angiotensin II in the hippocampus. A histochemical and electrophysiological study | Q70681508 | ||
| Dose and time dependency of angiotensin II inhibition of hippocampal long-term potentiation | Q70813999 | ||
| The carboxyl terminus of GLUT4 contains a serine-leucine-leucine sequence that functions as a potent internalization motif in Chinese hamster ovary cells | Q71246222 | ||
| Angiotensin II blockade of long-term potentiation at the perforant path--granule cell synapse in vitro | Q71524337 | ||
| Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats | Q71725922 | ||
| Effects of non-peptide angiotensin II-receptor antagonists on pentylenetetrazol kindling in mice | Q71788061 | ||
| Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function | Q71911932 | ||
| AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues | Q72120113 | ||
| GLUT1 deficiency syndrome--2007 update | Q34667235 | ||
| Neuronal apoptosis after brief and prolonged seizures. | Q34763745 | ||
| Functional and morphological changes in the hippocampal neuronal circuits associated with epileptic seizures | Q34970027 | ||
| On the Role of Somatostatin in Seizure Control: Clues from the Hippocampus | Q35545445 | ||
| Resistance to excitotoxin-induced seizures and neuronal death in mice lacking the preprotachykinin A gene | Q35733687 | ||
| Brain angiotensin II and synaptic transmission | Q35883454 | ||
| Oxytocin, vasopressin, and social recognition in mammals | Q35890733 | ||
| Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility? | Q35988212 | ||
| Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. | Q36174208 | ||
| Parahippocampal networks, intractability, and the chronic epilepsy of kindling. | Q36355836 | ||
| Wide distribution of immunoreactive renin in nerve cells of human brain | Q36407017 | ||
| The role of postsynaptic calcium in the induction of long-term potentiation | Q36472942 | ||
| Aminopeptidase A inhibitors as potential central antihypertensive agents | Q36675846 | ||
| Angiotensin IV Reverses the Acute Cerebral Blood Flow Reduction after Experimental Subarachnoid Hemorrhage in the Rat | Q36676246 | ||
| Serotonin and epilepsy | Q36703063 | ||
| Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: are they effective or relevant? | Q36720349 | ||
| Adenosine-based cell therapy approaches for pharmacoresistant epilepsies. | Q36788952 | ||
| Enzymatic pathways of the brain renin-angiotensin system: unsolved problems and continuing challenges. | Q36817565 | ||
| Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist | Q36837133 | ||
| Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes | Q36854986 | ||
| Neuropsychological correlates of hypertension: review and methodologic considerations | Q36858700 | ||
| Epileptogenesis in the dentate gyrus: a critical perspective | Q36926926 | ||
| Toward an integrative perspective on hippocampal function: from the rapid encoding of experience to adaptive behavior | Q37003959 | ||
| The basic science of memory as it applies to epilepsy | Q37019193 | ||
| Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets | Q37045324 | ||
| Brain angiotensin receptors and binding proteins | Q37049094 | ||
| The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain | Q37054961 | ||
| Somatostatin: an endogenous antiepileptic | Q37067748 | ||
| Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases | Q37479257 | ||
| Captopril and enalapril improve cognition and depressed mood in hypertensive patients. | Q38421469 | ||
| Effect of I.C.V. injection of AT4 receptor ligands, NLE1-angiotensin IV and LVV-hemorphin 7, on spatial learning in rats. | Q38450522 | ||
| The cytoplasmic tail of the T cell receptor zeta chain is required for signaling via CD26. | Q39255555 | ||
| Long-lasting enhancement of synaptic excitability of CA1/subiculum neurons of the rat ventral hippocampus by vasopressin and vasopressin(4-8). | Q39436110 | ||
| Trandolapril attenuates acquisition of conditioned avoidance in rats. | Q42636579 | ||
| AT(2) but not AT(1) receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats. | Q42669920 | ||
| The amino terminus of insulin-responsive aminopeptidase causes Glut4 translocation in 3T3-L1 adipocytes | Q42795999 | ||
| Insulin stimulates cell surface aminopeptidase activity toward vasopressin in adipocytes | Q42802101 | ||
| Characterization of the insulin-regulated endocytic recycling mechanism in 3T3-L1 adipocytes using a novel reporter molecule | Q42805489 | ||
| Potentiation of cholinergic transmission in the rat hippocampus by angiotensin IV and LVV-hemorphin-7. | Q43543037 | ||
| Comparative studies on the memory-enhancing actions of captopril and losartan in mice using inhibitory shock avoidance paradigm | Q43602969 | ||
| Interaction between angiotensin IV and adenosine A(1) receptor related drugs in passive avoidance conditioning in rats | Q43620962 | ||
| AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. | Q43641852 | ||
| Angiotensin IV enhances LTP in rat dentate gyrus in vivo | Q43713596 | ||
| Effects of angiotensin III and angiotensin IV on pentylenetetrazol seizure susceptibility (threshold and kindling): interaction with adenosine A(1) receptors | Q43796454 | ||
| A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits | Q43814000 | ||
| Interaction of angiotensin II and III with adenosine A(1) receptor-related drugs in passive avoidance conditioning in rats | Q43865380 | ||
| Heightened seizure severity in somatostatin knockout mice | Q43873850 | ||
| Angiotensin IV is a potent agonist for constitutive active human AT1 receptors. Distinct roles of the N-and C-terminal residues of angiotensin II during AT1 receptor activation | Q43990144 | ||
| Tonin expression in the rat brain and tonin-mediated central production of angiotensin II. | Q44014470 | ||
| Oxytocin induces long-term depression on the rat dentate gyrus: possible ATPase and ectoprotein kinase mediation | Q44070619 | ||
| Role of AT2 receptor in the brain in regulation of blood pressure and water intake | Q44185525 | ||
| Expression of insulin-responsive glucose transporter GLUT4 mRNA in the rat brain and spinal cord: an in situ hybridization study | Q44198241 | ||
| Genetic disruption of cortical interneuron development causes region- and GABA cell type-specific deficits, epilepsy, and behavioral dysfunction. | Q44281916 | ||
| Effects of arginine-vasopressin (AVP) on long-term potentiation in intact anesthetized rats | Q44308093 | ||
| The effects of sarmesin, an Angiotensin II analogue on seizure susceptibility, memory retention and nociception | Q44332885 | ||
| Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors | Q44334254 | ||
| Hippocampal dynorphin B injections impair spatial learning in rats: a kappa-opioid receptor-mediated effect | Q44349020 | ||
| The renin-angiotensin system is upregulated in the cortex and hippocampus of patients with temporal lobe epilepsy related to mesial temporal sclerosis. | Q44361362 | ||
| Inhibition of L-type voltage dependent calcium channels causes impairment of long-term potentiation in the hippocampal CA1 region in vivo | Q44371592 | ||
| Ethanol-induced suppression of LTP can be attenuated with an angiotensin IV analog | Q44397760 | ||
| Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor | Q44413571 | ||
| The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial | Q44417511 | ||
| Effects of angiotensin II and its receptor antagonists on motor activity and anxiety in rats | Q44495613 | ||
| Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP). | Q44518988 | ||
| Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation. | Q44550250 | ||
| Effect of angiotensin IV on the acquisition of the water maze task and ryanodine channel function. | Q44588430 | ||
| Influence of losartan and atenolol on memory function in very elderly hypertensive patients | Q44632352 | ||
| Activation of long-term synaptic plasticity causes suppression of epileptiform activity in rat hippocampal slices | Q44730127 | ||
| Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension | Q44745545 | ||
| Epilepsy duration, febrile seizures, and cerebral glucose metabolism | Q44792016 | ||
| Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits | Q44828738 | ||
| Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist | Q44875167 | ||
| Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors | Q44893909 | ||
| Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms | Q45012094 | ||
| Metabolism of angiotensin II is required for its in vivo effect on dopamine release in the striatum of the rat. | Q45018901 | ||
| Hepatocyte growth factor improved learning and memory dysfunction of microsphere-embolized rats | Q45076516 | ||
| Hepatocyte growth factor as an enhancer of nmda currents and synaptic plasticity in the hippocampus | Q45079676 | ||
| Down-regulation of dopamine D1 and D2 receptors in the basal ganglia of PTZ kindling model of epilepsy: effects of angiotensin IV. | Q45080789 | ||
| Differential modulation of baroreflex control of heart rate by neuron- vs. glia-derived angiotensin II. | Q45092023 | ||
| Angiotensin II blocks memory consolidation through an AT2 receptor-dependent mechanism. | Q45155033 | ||
| The enhancing effects of hippocampal infusions of glucose are not restricted to spatial working memory | Q45275001 | ||
| Alleviation of Abeta-induced cognitive impairment by ultrasound-mediated gene transfer of HGF in a mouse model | Q45875353 | ||
| Candesartan and cognitive decline in older patients with hypertension: a substudy of the SCOPE trial. | Q46204112 | ||
| Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension. | Q46426608 | ||
| In vivo modulatory action of extracellular glutamate on the anticonvulsant effects of hippocampal dopamine and serotonin | Q46536791 | ||
| Secretory vesicle aminopeptidase B related to neuropeptide processing: molecular identification and subcellular localization to enkephalin- and NPY-containing chromaffin granules | Q46537906 | ||
| Somatostatin depresses long-term potentiation and Ca2+ signaling in mouse dentate gyrus | Q46549980 | ||
| Brain and peripheral angiotensin II type 1 receptors mediate renal vasoconstrictor and blood pressure responses to angiotensin IV in the rat. | Q46656502 | ||
| Induction and maintenance of late-phase long-term potentiation in isolated dendrites of rat hippocampal CA1 pyramidal neurones | Q46658286 | ||
| Direct enhancement of hippocampal dopamine or serotonin levels as a pharmacodynamic measure of combined antidepressant-anticonvulsant action. | Q46672872 | ||
| Effect of D(3) dopamine receptors blockade on the cognitive effects of angiotensin IV in rats. | Q46688100 | ||
| Glutamatergic regulation of the p70S6 kinase in primary mouse neurons | Q46720415 | ||
| Disruption of interneuron development | Q46733519 | ||
| Valsartan abolishes most of the memory-improving effects of intracerebroventricular angiotensin II in rats. | Q46816577 | ||
| Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients | Q46819242 | ||
| Dynorphin A (2-13) improves mecamylamine-induced learning impairment accompanied by reversal of reductions in acetylcholine release in rats | Q46824669 | ||
| Angiotensin IV enhances phosphorylation of 4EBP1 by multiple signaling events in lung endothelial cells | Q46846204 | ||
| Evidence supporting a functional role for intracellular renin in the brain | Q46919174 | ||
| CCKB-receptor activation augments the long-term potentiation in guinea pig hippocampal slices | Q46966538 | ||
| Intracerebroventricular effects of angiotensin II on a step-through passive avoidance task in rats. | Q47326003 | ||
| Hepatocyte growth factor attenuates cerebral ischemia-induced learning dysfunction | Q47351828 | ||
| Localization of components of the renin-angiotensin system in the suprachiasmatic nucleus of normotensive Sprague-Dawley rats: part B. angiotensin II (AT1)-receptors, a light and electron microscopic study | Q47598998 | ||
| Localization of components of the renin-angiotensin system in the suprachiasmatic nucleus of normotensive Sprague-Dawley rats: part A. angiotensin I/II, a light and electron microscopic study | Q47599012 | ||
| Angiotensin II inhibits long-term potentiation within the lateral nucleus of the amygdala through AT1 receptors | Q47698919 | ||
| Involvement of dopamine receptors in beneficial effects of tachykinins on scopolamine-induced impairment of alternation performance in mice | Q47771462 | ||
| V1a receptor knockout mice exhibit impairment of spatial memory in an eight-arm radial maze | Q47907446 | ||
| Inhibition by [Arg8]-vasopressin of long term potentiation in guinea pig hippocampal slice | Q47931436 | ||
| Cholecystokinin (CCK-8S) prolongs 'unsaturated' theta-pulse induced long-term potentiation in rat hippocampal CA1 in vitro | Q48115959 | ||
| The 140-kDa protein of blood-brain barrier-associated pericytes is identical to aminopeptidase N. | Q48118260 | ||
| Hepatocyte growth factor-induced enhancement of dendritic branching is blocked by inhibitors of N-methyl-D-aspartate receptors and calcium/calmodulin-dependent kinases | Q48122008 | ||
| Localization of renin expressing cells in the brain, by use of a REN-eGFP transgenic model | Q48140732 | ||
| Central pressor actions of aminopeptidase-resistant angiotensin II analogs: challenging the angiotensin III hypothesis | Q48182833 | ||
| PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III. | Q48199745 | ||
| Psychotropic effects of angiotensin II and III in rats: locomotor and exploratory vs cognitive behaviour | Q48208370 | ||
| Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning | Q48218315 | ||
| Angiotensin AII AT1 receptor mediates ethanol-diazepam inhibition of hippocampal LTP. | Q48228448 | ||
| Learning and anxiety in angiotensin-deficient mice | Q48231386 | ||
| Use of a structural analogue versus a stable isotope labeled internal standard for the quantification of angiotensin IV in rat brain dialysates using nano-liquid chromatography/tandem mass spectrometry | Q48258707 | ||
| Role of angiotensin II and AT1 receptors in hippocampal LTP. | Q48276912 | ||
| Angiotensin II suppresses long-term depression in the lateral amygdala of mice via L-type calcium channels | Q48278805 | ||
| Opposite effects of angiotensin II and IV in the lateral nucleus of the amygdala | Q48306989 | ||
| An examination of the relations between hippocampal long-term potentiation, kindling, afterdischarge, and place learning in the water maze | Q48314345 | ||
| Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II. | Q48318272 | ||
| Localization of immunoreactive glutamyl aminopeptidase in rat brain. I. Association with cerebral microvessels | Q48318283 | ||
| In vitro effect of angiotensin II on GABA release in rat hippocampus | Q48333660 | ||
| Conservation of total synaptic weight through balanced synaptic depression and potentiation | Q48346111 | ||
| Participation of angiotensin II in learning and memory. II. Interactions of angiotensin II with dopaminergic drugs | Q48358655 | ||
| High-performance liquid chromatographic analysis of 'specifically bound' label after [125I]angiotensin II binding to rat brain membranes | Q48364722 | ||
| Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory | Q48381985 | ||
| Oxytocin improves long-lasting spatial memory during motherhood through MAP kinase cascade | Q48382169 | ||
| Differential behavioral effects of angiotensin II microinjected unilaterally into the CA1 hippocampal area | Q48407930 | ||
| Angiotensin II disrupts inhibitory avoidance memory retrieval | Q48447208 | ||
| D2 dopamine receptor blockade prevents cognitive effects of Ang IV and des-Phe6 Ang IV. | Q48447385 | ||
| P433 | issue | 4 | |
| P921 | main subject | synaptic plasticity | Q1551556 |
| P304 | page(s) | 315-339 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | CNS Neuroscience & Therapeutics | Q5013184 |
| P1476 | title | Ang II and Ang IV: unraveling the mechanism of action on synaptic plasticity, memory, and epilepsy | |
| P478 | volume | 14 |
| Q36098738 | AGTR1 gene variation: association with depression and frontotemporal morphology |
| Q49721288 | Brain Renin-Angiotensin System Blockade Attenuates Methamphetamine-Induced Hyperlocomotion and Neurotoxicity |
| Q37091405 | Central administration of angiotensin IV rapidly enhances novel object recognition among mice |
| Q38461657 | Cerebroprotective effects of RAS inhibitors: Beyond their cardio-renal actions. |
| Q34543485 | Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers. |
| Q46799226 | Enalapril enhances the anticonvulsant activity of lamotrigine in the test of maximal electroshock |
| Q94353827 | Erratum |
| Q30530935 | Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents |
| Q24635261 | Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs |
| Q36415423 | Importance of the brain Angiotensin system in Parkinson's disease |
| Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
| Q34413859 | Neuropeptides as targets for the development of anticonvulsant drugs. |
| Q38217456 | Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors |
| Q46322831 | Physiological and pathophysiological functions of different angiotensins in the brain |
| Q46316918 | Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease |
| Q64274255 | Role of the Angiotensin Pathway and its Target Therapy in Epilepsy Management |
| Q36520049 | The Angiotensin II Type 2 Receptor in Brain Functions: An Update |
| Q38005611 | The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases |
| Q50679867 | The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice. |
| Q35928365 | The role of insulin-regulated aminopeptidase in MHC class I antigen presentation |
Search more.